- Home
- SFHG vs NCNA Comparison
SFHG vs NCNA Comparison
Compare SFHG & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SFHG | NCNA |
|---|---|---|
| Founded | 1993 | 1997 |
| Country | Hong Kong | United Kingdom |
| Employees | 216 | N/A |
| Industry | Publishing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2M | 13.8M |
| IPO Year | 2024 | 2017 |
Fundamental Metrics
Financial Performance| Metric | SFHG | NCNA |
|---|---|---|
| Price | $0.78 | $3.62 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 135.9K | 60.5K |
| Earning Date | 10-30-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $19,577,200.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.56 | N/A |
| 52 Week Low | $0.32 | $2.78 |
| 52 Week High | $2.32 | $273.92 |
Technical Indicators
Market Signals| Indicator | SFHG | NCNA |
|---|---|---|
| Relative Strength Index (RSI) | 53.79 | 50.24 |
| Support Level | $0.70 | $3.50 |
| Resistance Level | $0.84 | $3.77 |
| Average True Range (ATR) | 0.09 | 0.19 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 28.31 | 85.48 |
Price Performance
Historical ComparisonAbout SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.